- Skin toxicity of BRAF and MEK inhibitors2021 | First Faculty of Medicine
- The Role of BRAF/MEK Inhibition in Metastatic Malignant Melanoma - a Case Study2016 | Faculty of Medicine in Hradec Králové
- Effect of target therapy with BRAF and MEK inhibitors on the immune system in metastatic melanoma2023 | First Faculty of Medicine
- Patient with abrain metastases of malignant melanoma a long-term surviving with BRAF and MEK inhibitor in combination therapy2018 | First Faculty of Medicine
- Patient with lung metastases of malignant melanoma who have long-term survival in combination therapy BRAF and MEK inhibitors2019 | First Faculty of Medicine
- Old Czech translation of Mk 3:21 and its exegetical context2022 | Catholic Theological Faculty
- BRAF/MED inhibitors in the treatment of malignant melanoma2018 | Third Faculty of Medicine
- The parable about bad vine-growers, Mark 12,1-122003 | Protestant Theological Faculty
- Long-term therapeutic response after encorafenib and binimetinib therapy - case report2023 | First Faculty of Medicine
- Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF-Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial2023 | First Faculty of Medicine
- Dual targeted therapy in patients with malignant melanoma2017 | Faculty of Medicine in Hradec Králové
- Position of adjuvant therapy in the therapy of melanoma2018 | First Faculty of Medicine
- Monte Carlo simulations of the electron currents collected by electrostatic probes2004 | Publication without faculty affiliation
- Generalizovaný maligní melanom léčený kombinací BRAF a MEK inhibitorů ve 3. linii terapie2023 | First Faculty of Medicine
- The MEK-ERK-MST1 Axis Potentiates the Activation of the Extrinsic Apoptotic Pathway during GDC-0941 Treatment in Jurkat T Cells2019 | Faculty of Science, Central Library of Charles University
- Mutations in the RAS/MAPK Pathway Drive Replication Repair-Deficient Hypermutated Tumors and Confer Sensitivity to MEK Inhibition2021 | Second Faculty of Medicine
- The Significance of BRAFV600E Mutation in Thyroid Cancer in Terms of Novel Targeted Therapies - Overview of Current Knowledge and Studies2018 | Faculty of Medicine in Hradec Králové
- Comparison of Collision Treatment Methods in PIC-MC Plasma2006 | Faculty of Mathematics and Physics
- Mechanisms of resistance in malignant melanoma treated by targeted therapy2020 | First Faculty of Medicine
- The Time of the Bridegroom (Mark 2:18-20)2021 | Catholic Theological Faculty
- Léčba generalizovaného maligního melanomu kombinací inhibitoru BRAF a inhibitoru MEK - kasuistiky2016 | First Faculty of Medicine
- Neurofibromatosis von Recklinghausen type I (NF1) - clinical picture in childhood, diagnosis and therapy2023 | Second Faculty of Medicine
- The Question about Paying Taxes (Mark 12:13-17)2001 | Protestant Theological Faculty
- MC simulations of fluorescence correlation spectroscopy2007 | Faculty of Science
- Stimuli-responsive amphiphilic shells of kinetically frozen polymeric micelles in aqueous media: Monte Carlo simulations and comparison to self-consistent field calculations2008 | Faculty of Science
- Trametinib2016 | First Faculty of Medicine
- Housing satisfaction research in the City District Prague 22Publication without faculty affiliation
- The Baptism of je Lord as the Quadruplicate Beginning (Mark 1:9-11)2021 | Protestant Theological Faculty
- What is Easier? Mark 2:1-12 and the Evangelist's Grasp of the Story of Jesus2021 | Protestant Theological Faculty
- Research Report University Hospital for clinical assessment BRF 115532Publication without faculty affiliation